LEGION NARROW PS OXIN SZ 6N RT and JRNY II BCS FEMORAL OXIN LT SZ 5
FDA Device Recall #Z-1099-2022 — Class II — April 19, 2022
Recall Summary
| Recall Number | Z-1099-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 19, 2022 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Smith & Nephew Inc |
| Location | Memphis, TN |
| Product Type | Devices |
| Quantity | 16 units |
Product Description
LEGION NARROW PS OXIN SZ 6N RT and JRNY II BCS FEMORAL OXIN LT SZ 5
Reason for Recall
It was reported that a JOURNEY II BCS Femoral OXIN LT SZ5 was in a box labelled as a LEGION NARROW PS OXIN SZ 6N RT.
Distribution Pattern
Worldwide distribution - US Nationwide distribution in the states of CT, NC, CO, SC, VA, FL, IL, CA and the country of Japan.
Lot / Code Information
LEGION NARROW PS OXIN SZ 6N RT: Model Number: 71421276; Lot: 21JM17389; UDI: (01)0885558234259(17)310925(10)21JM17389 JRNY II BCS FEMORAL OXIN LT SZ 5: Model Number: 74022125; Lot: 21JM18618; UDI: (01)00885556170410(17)310926(10)21JM18618
Other Recalls from Smith & Nephew Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0282-2025 | Class II | smith&nephew LEGION OXINIUM POSTERIOR STABILIZE... | Oct 2, 2024 |
| Z-0281-2025 | Class II | smith&nephew GENESIS II NONPOROUS POSTERIOR STA... | Oct 2, 2024 |
| Z-0277-2025 | Class II | smith&nephew LEIGON OXINIUM CONSTRAINED NONPORO... | Oct 2, 2024 |
| Z-0278-2025 | Class II | smith&nephew LEIGON OXINIUM CONSTRAINED NONPORO... | Oct 2, 2024 |
| Z-1901-2024 | Class II | smith&nephew OXINIUM Femoral Head 12/14 Taper, ... | Apr 24, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.